Lexeo Therapeutics (LXEO) Return on Equity [ROE] (2024 - 2026)
Lexeo Therapeutics (LXEO) reported Return on Equity [ROE] of -37.41% for Q2 2026, up 63.48 percentage points from -100.89% a year earlier but down 0.81 percentage points from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Return on Equity [ROE] (2024 - 2026) Analysis & Trends
For FY2025, Lexeo Therapeutics posted Return on Equity [ROE] of -55.00%, up 30.37 percentage points from FY2024.
- By year, Return on Equity [ROE] came in at -85.37% in FY2024 (+22769.71 pp) and -22855.08% in FY2023.
- Five-year quarterly Return on Equity [ROE] spans a low of -106.66% in Q1 2025 and a high of -36.60% in Q1 2026.
- Year over year, Return on Equity [ROE] has now increased in each of the last three quarters, with an average year-over-year change of +2.58 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -36.60% (Q1 2026), -54.40% (Q4 2025) and -81.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.97% |
| 10 | Lexeo Therapeutics | 248.75 Mn | -411.66 Mn | - | -37.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.41% |
| Mar 31, 2026 | -36.60% |
| Dec 31, 2025 | -54.40% |
| Sep 30, 2025 | -81.04% |
| Jun 30, 2025 | -100.89% |
| Mar 31, 2025 | -106.66% |
| Dec 31, 2024 | -76.77% |
| Sep 30, 2024 | -56.92% |
| Jun 30, 2024 | -44.39% |
| Mar 31, 2024 | -46.83% |
API Access
Lexeo Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();